Drug
Polysaccharide-K clinical trials
Also written Krestin.
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2013 | 1 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 8
University of Washington (1) · Hokuriku-Kinki Immunochemotherapy Study Group (1) · Eastern Network of Cancer Immunological Therapy, Japan (1) · Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (1) · Tokyo Metropolitan Oncology Group (1) · Hokkaido Gastrointestinal Cancer Study Group (1) · University of Toyama (1) · Bastyr University (1)
Often tested with
Tested in the same studies.
Tegafur (1) · Gimeracil (1) · Potassium oxonate (1) · Tegafur-gimeracil-oteracil (1) · Irinotecan (1) · Cisplatin (1)
Related medicines
As reviewed, each with the page that says it.
- One of Immunologic Factors source
Studies
Open first, then newest update. How each study uses polysaccharide-K is read from its arms, and is right about nine times in ten.
Testing it · 8
- Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody TherapyCompletedPhase 1/2University of WashingtonNCT01922921Written as Polysaccharide-K
- Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSKCompletedPhase 3Hokuriku-Kinki Immunochemotherapy Study GroupNCT00216034Written as Krestin (PSK)
- A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate CancerWithdrawnPhase 1Bastyr UniversityNCT01685489Written as Docetaxel, PSK®
- A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal CancerStatus unknownPhase 3Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment GroupNCT00385970Written as Krestin (PSK)
- Study of TS-1 or TS-1 + PSK for Gastric Cancer PatientsStatus unknownPhase 3Tokyo Metropolitan Oncology GroupNCT00687843Written as Krestin (PSK)
- Randomized Phase III Adjuvant Study for Stage III Colorectal CancerStatus unknownPhase 3Hokkaido Gastrointestinal Cancer Study GroupNCT00209742Written as Krestin
- Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric CarcinomaTerminatedPhase 2/3Eastern Network of Cancer Immunological Therapy, JapanNCT00503321Written as Tegafur/gimeracil/oteracil potassium (S-1), Krestin (PSK)
- Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung CancerStatus unknownPhase 2University of ToyamaNCT00546130Written as Krestin
Codes
What other systems call polysaccharide-K · ClinicalTrials.gg INT002502
- MeSH (NLM) C010770polysaccharide-KConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 3X48A86C8KOne source NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C010770 | polysaccharide-K | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 3X48A86C8K | — | One source NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.